Jon Cuthbert

NeuroScientific Biopharmaceuticals (ASX:NSB) has announced encouraging results from its Special Access Program for patients with fistulising Crohn's disease.

DPM Metals (ASX:DPM) reported preliminary production results for the fourth quarter and full year ended Dec. 31, 2025, marking the eleventh consecutive year the company has met its gold production guidance

Karyopharm Therapeutics (NASDAQ:KPTI) is entering a pivotal year for its oncology pipeline, with the company forecasting a duo of high-stakes clinical trial readouts that could redefine its market position as its current cash runway nears its end.

In a move that reshapes the competitive landscape of Silicon Valley, Alphabet (NASDAQ:GOOGL) and Apple (NASDAQ:AAPL) have entered into a multi-year partnership to base the next generation of Apple’s artificial intelligence on Google’s Gemini models.

Masimo Corp. (NASDAQ:MASI) reported preliminary 2025 results that landed at the high end of its guidance, signaling a successful first year under the leadership of Chief Executive Officer Katie Szyman.

Planet Fitness (NYSE:PLNT) reported a surge in year-end membership and same-club sales for 2025, signaling that its low-cost "Judgment Free Zone" model is continuing to capture market share among younger, budget-conscious consumers.

KORU Medical Systems (NASDAQ:KRMD) reported preliminary 2025 revenue that exceeded the high end of its guidance on Monday, as the medical technology firm prepares to pivot from its core immunology business into the high-growth oncology market.

Zura Bio Limited 9NASDAQ:ZURA) announced it is expanding the patient population for its mid-stage trial of tibulizumab in hidradenitis suppurativa (HS), a move intended to bolster the study’s statistical power as the company prepares for a critical data readout later this year.

Las Vegas-based Allegiant Travel Co. (NASDAQ:ALFT) and Minneapolis-based Sun Country Airlines Holdings (NASDAQ:SNCY) announced Sunday that Allegiant has agreed to acquire Sun Country in an all-cash-and-stock transaction valued at approximately $1.5 billion, marking the latest move in a wave of consolidation among smaller U.S. carriers.

New research suggests US government pressure, not banks, is behind most debanking cases affecting crypto firms.